Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells

Fig. 4

Cells treated with NMDA a, b and glutamate c, d for 72 h analyzed for cell viability (MTS Assay; a, c; n = 9) and cell death (LDH assay; b, d; n = 6). No difference occurs in the NMDA treated cells. Cells exposed to glutamate show decreased cell viability and increased LDH levels at a concentration of 10 mM compared to the control (CTR). Error bars show standard deviation. (** p < 0.01; *** p < 0.001)

Back to article page